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Aim of Study 
 
The aim of the present work is to investigate the role of CDK5RAP2 on brain 
development and modulation of neuronal differentiation in zebrafish embryos. 
 
Our specific aims were: 
1) To determine the expression of zCdk5rap2 during zebrafish development (by 
immunohistochemistry and in situ hybridization) 
2) To knockdown Cdk5rap2 function by injecting anti sense oligo morpholinos and 
determine their effect in production of microcephalic phenotypes, cell polarity, 
and neurogenesis. 
3) To validate morpholino and custom made antibody specificity. 
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Abstract 
 
 
Primary Microcephaly is a human brain disease that develops during gestation and 
it is characterized by a small brain phenotype. Several centrosome-associated proteins 
have been associated with this disease (Cdk5rap2, Aspm, Wdr62, etc). They are associated 
with regulation of many characteristics of cell division. It has been suggested that 
microcephalies can arise from disruption of progenitors divisions and cell cycle exit. The 
aim of the present work was to investigate the role of CDK5RAP2 on brain development 
and modulation of neuronal differentiation in zebrafish embryos. 
 
To abrogate Cdk5rap2 function antisense oligo morpholinos predicted to block 
protein translation and splicing between exon 4 and 5 were injected. Brain size was 
measured; neurogenesis rate and apical/basal progenitor divisions were evaluated in 
telencephalon of zebrafish embryos injected with control and CDK5RAP2 morpholinos. 
The validations of CDK5RAP2 antisense oligo morpholinos and antibody specificity were 
also undertaken. 
 
Preliminary results show that CDK5RAP2 reduced function disrupts brain growth, 
cell proliferation and neurogenesisin zebrafish embryos. Microcephaly does not result 
from an increase in cell death caused by morpholino injection neither from a disruption of 
polarity proteins. We could not observed an increase in neurogenesis as previously 
reported. In telencephalon of zebrafish embryos, with morpholinos injection, 
neurogenesis and cell proliferation are decreased. These results might suggest that 
progenitors maybe arrested at some point in the cell cycle or in increased cell cycle 
length. Further live-imaging experiments are required to confirm these observations. So 
far, the present work suggests that decrease on CDK5RAP2 function causes 
microcephalies and prevents neuronal differentiation. 
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Resumo 
 
Microcefalia de origem primária é uma doença caracterizada por afectar o 
desenvolvimento cerebral. Cdk5rap2, Aspm e Wdr62 são algumas das proteínas 
centrossomáis que têm sido descritas como sendo associadas a microcefalias. As 
proteínas associadas aos centrossomas são evidenciadas como reguladoras da divisão 
celular e tem sido sugerido que a saída prematura do ciclo celular e a interferência com o 
tipo de divisão de células progenitoras pode causar microcefalias. O objetivo deste 
estudo consistiu em investigar o papel de Cdk5rap2 no desenvolvimento cerebral e na 
modulação da diferenciação neuronal em embriões de peixe zebra. 
 
A disfunção de Cdk5rap2 foi conseguida através da injeção de oligoantisense 
morpholinos que estão desenhados de forma a bloquear a tradução proteica e o splicing 
entre o exão 4 e 5 que, teoricamente, levaria à formação de uma proteína truncada. De 
forma a avaliar os efeitos da injeção dos morpholinos contra CDK5RAP2 e morpholinos 
controlo, foi medido o tamanho do cérebro e foram contadas o número células 
presentes no telencéfalo. A validação do oligoantisense morpholino para CDK5RAP2 e a 
especificidade do anticorpo desenhado contra CDK5RAP2 de peixe zebra foram também 
estudadas. 
 
Os resultados obtidos sugerem que a redução da função de CDK5RAP2 afeta o 
crescimento do cérebro, a proliferação celular e a neurogénese no peixe zebra. As 
microcefalias observadas não são resultantes de um aumento da morte celular ou de 
algum tipo de interferência causada nas proteínas de manutenção de polaridade 
possivelmente resultante da injeção do morpholino. A diminuição da expressão de 
Cdk5rap2 não induziu um aumento da neurogénese, como descrito anteriormente em 
mamíferos. No entanto, a injeção de morpholino induziu uma diminuição da neurogénese. 
Quando foi injetado morpholino para Cdk5rap2, foi observado uma diminuição da 
proliferação celular. Desta forma os resultados obtidos podem sugerir que existe um 
bloqueio do ciclo celular, em alguma das suas fases, ou até o aumento do tempo em que a 
célula permanece em divisão. Estes resultados deverão ser confirmados realizando 
ensaios de imagem em tempo real (live-imaging) de modo a avaliar uma mudança no 
destino previsto da célula entre a diferenciação ou a proliferação. 
Resumo 
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Os resultados obtidos no presente trabalho sugerem existir uma diminuição na 
diferenciação neuronal e um desenvolvimento de microcefalias com a injeção do 
morpholino contra CDK5RAP2 
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Introduction 
 
Brain development 
 
The central nervous system (CNS) of vertebrates is specified during early 
embryonic development and is derived from the ectodermal layer. The neural plate is 
formed by neuroepithelial cells (also called neural progenitors) and later generates the 
neural tube that is already patterned along the anteroposterior axis in brain and spinal 
cord. The telencephalon is the most anterior part of the neural tube and in mammalian 
systems has the highest rate of cell proliferation and growth. Neuroepithelial cells (also 
known as radial glia in mammalian cortex) initially proliferate symmetrically to generate 
two other neuroepithelial cells. This increases the neural progenitor pool and determines 
final brain size. Later in embryonic development, neuroepithelial cells start differentiating 
by undergoing asymmetric divisions that generate a radial glia cell and a neuron, which will 
migrate to different parts of the brain. For this reason, neuroepithelial cells are often 
called the mother cells of all brain cells. During the embryonic development, by extending 
axons and dendrites neurons will establish communications through the synapses with 
other neurons. Small perturbations on different aspects of brain development can lead to 
several deformities such as anencephaly, spinal bifida, microcephalies and many other 
developmental brain disorders. (Mochida 2008; Lizarraga et al. 2010 and Woods et al. 
2005) 
 
Primary microcephalies 
 
Microcephaly is a rare disease characterized by small brain phenotype determined 
by significant reduction in the occipital-frontal head circumference (OFC) compared with 
age and sex matched controls. Individuals suffering from this disease may suffer from 
intellectually disability, epilepsy, and others (Mochida 2008).  If microcephaly develops 
during embryonic development is called primary microcephaly and it is detectable prior 
to 36 weeks of gestation, while secondary microcephaly develops in general after birth.  
The exact cause(s) of microcephaly are unknown and there are currently no 
therapies. However, have been many genetic and environmental factors linked to 
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microcephaly, such as alcohol consumption by mother prior to birth. Genetic factors are 
usually associated with failure or decrease in neurogenesis, loss of progenitors population, 
cell cycle arrest, cell death, neuronal degeneration and/or defects on neuronal migration 
have been linked to small brain phenotype in several organisms (Issa et al. 2013b).  The 
present thesis will focus on the genetic disorders at the origin of primary microcephalies.  
Primary microcephaly have been clinically divided in to four subtypes: 1) primary 
microcephaly with dwarfism – it is important to distinguish between proportionate 
growth retardation where the OFC is reduced to a greater extent than length and 
weight; 2) primary microcephaly, with dysmorphic features and/or congenital anomalies; 
3) primary microcephaly with additional clinical features such as mitochondrial and 
metabolic disorders which are usually predominant; and lastly 4) the ‘autosomal recessive 
primary microcephaly’ (MCPH) phenotype which is usually diagnosed in a child presenting 
with developmental delay of mild–moderate degree with a normal brain scan but no 
other abnormal growth, and dysmorphic or neurological features (Woods et al. 2013). 
The present work will focus on primary microcephalies that result from centrosomal 
proteins misfunction. This will include microcephalies subtypes 1 (Pericentrin) and 4 
(Nedd1, Aspm, Wdr62, Cdk5rap2, CenpJ, Ninein).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Localization of MCPH proteins in dividing cell. MCPH proteins are localized to the 
centrosome and/or mitotic spindle poles. Adapted by A.M. Kaindl et al. 2010. 
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Centrosomal proteins and primary microcephalies. 
 
So far, every gene product found implicated in MCPH has been reported to display 
centrosomal localization. Centrosomes are small organelles that regulate many aspects of 
cell division. The centrosome, a key microtubule organizing centre, is composed of 
centrioles, embedded in a protein-rich matrix. Centrosomes control the internal spatial 
organization of somatic cells, and as such contribute to cell division, cell polarity and 
migration. Centrosomal genes are targeted by mutations in numerous human 
developmental disorders, ranging from diseases exclusively affecting brain development, 
through global growth failure syndromes (Chavali et al. 2014). Disruptions of centrosomal 
proteins function, such as; PERICENTRIN, NEEDd1, ASPM, WDR62, NINEIN CENPJ and 
CDJ5RAP2, have been reported as cause of neurogenesis defects.  
PERICENTRIN localizes to the pericentriolar protein matrix and functions in 
ciliogenesis, centrosomal recruitment, and mitotic spindle assembly. PERICENTRIN 
recruits CDK5RAP2 to the centrosome to support its critical role in the maintenance of 
the progenitor pool during corticogenesis (Buchman et al. 2010).  
NEED1 is another protein that plays a role in mitosis through its interaction with 
gamma-tubulin. Its known that depletion of NEDD1 causes impaired centrosome and 
chromatin microtubules assembly that results in the failure of microtubule nucleation and 
prevents proper spindle formation (Haren et al. 2006).  
The Aspm gene possesses multiple functions essential to the differentiation and 
proliferation of neural stem and progenitor cells in developing of central nervous system. 
The function of the ASPM protein in neural progenitor cell expansion, as well as the 
localization in mitotic spindle and centrosome, suggests that regulates brain development 
by a cell division-related mechanism. In addition, a loss of ASPM proteins causes a massive 
loss of germ cells, resulting in a severe reduction in the size of the testes and ovaries, 
reducing fertility (Fujimori et al. 2013).  
So far, 25 mutations of the Wdr62 gene have been reported in 27 families or 
individual patients worldwide, most of them predicted to produce truncated proteins. 
Wdr62 knockdown in cortical progenitors reduced their proliferative capacity, caused 
spindle orientation defects, decreased the integrity of centrosomes and displaced them 
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from spindle poles, and delayed mitotic progression (Farag et al. 2013).  
NINEIN, is important for positioning and anchoring the microtubules in epithelial 
cells and was demonstrated that NINEIN associates with the mother centrioles only. 
Have been reported that multiple alternatively spliced transcript variants that encode 
different isoforms of Ninein exist (Hong et al. 2000).  
CenpJ encodes the centromere protein CPAP, which is present at centrosomes 
and also in the cytoplasm of proliferating cells (Tang et al. 2009). Truncated mutations in 
CenpJ cause primary microcephaly and are associated with Seckel syndrome, a rare 
autosomal recessive disorder characterized by intrauterine and postnatal growth delay; 
microcephaly with mental retardation; and facial dysmorphisms (Bond et al. 2005). CENPJ 
has been shown to contribute to centriole location and formation by generating overly 
long centrioles (Shi et al. 2014).  
CDK5RAP2 (cyclin-dependent kinase 5 regulatory associated protein 2) is a 
centrosomal protein that can cause autosomal recessive primary microcephaly, a disorder 
caused by defective proliferation and cell-fate determination of neural progenitors during 
neurogenesis and the disruption of CDK5RAP2 function results in the disorganization of 
interphase microtubules and the formation of disrupted mitotic spindles. CDK5RAP2 
plays an essential role in the organization of microtubules by centrosomes (Jia et al. 2013). 
The present thesis focuses on CDK5RAP2 function. 
 
MCPH Type 3 (MCPH3) and CDK5RAP2 function 
 
In 2005, MCPH type 3 (MCPH3) was established to be caused by homozygous 
mutations of the Cyclin-dependent kinase 5 regulatory subunit-associated protein 2 (Cdk5rap2) 
gene (Bond et al. 2005). So far, seven different mutations have been identified in MCPH 
families (see table 1). They include homozygous mutations in 2 Pakistani families (Bond et 
al. 2005; Hassan et al. 2007); a truncating homozygous mutation was identified in a six 
year old girl born of consanguineous Somali parents (Pagnamenta et al. 2012). Compound 
heterozygous mutations have also been identified in two patients of Caucasian origin 
(Lancester et al. 2013; Tan et al. 2013). The Cdk5rap2 mutations range from a nonsense 
mutation in exon 4, an A to G transition in intron 26 introducing a new splice acceptor 
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site, a frame shift, a premature stop codon, and a nonsense mutation in exon 8. These 
three mutations have been proposed to lead to a truncated protein and loss of 
CDK5RAP2 function (Issa et al. 2013a). 
 
Table 1 - Mutations identified in the Cdk5rap2 gene in MCPH3 patients 
Family Origin Mutation Protein change Reference 
Pakistani c.243T>A p.S81X Bond et al. 2005 
Pakistani c.246T>A p.Y82X Hassan et al. 2007 
Somali c.700G>T p.E234X Pagnameta et al. 2012 
Caucasian  c.4546G>T p.E1516X Lancastrer et al. 2013 
Caucasian c.4672C>T p.R1558X Lancaster et al. 2013 
Caucasian and 
Cherokee ancestry 
c.524_528 del p.Q175Rfs.Ter42 Tan et al. 2013 
Caucasian and 
Cherokee ancestry 
c.4005-1G>A IVS26AS, G>A-1 Tan et al. 2013 
 
 
The Cdk5rap2 gene, for non-progressive phenotypes in humans, controls MCPH3. 
Neurodevelopmental studies of MCPH have shown that microcephaly begins to show 
evidence of decreased of cerebral cortex volume by the 24th week of gestation.  Recent 
works suggest that this small brain phenotype results from the reduction of progenitor 
pool and a premature cell cycle exit and neuronal differentiation. Neither neuroimaging 
nor neuropathological studies have been reported to date for humans MCPH phenotype 
(Issa et al. 2013b). 
 
CDK5RAP2 (cyclin-dependent kinase 5 regulatory associated 
protein 2) 
 
• CDK5RAP2 structure 
 Nagase et al. (2000) first cloned human Cdk5rap2 (designed as KIAA1633) through 
sequencing clones obtained from a size-fractionated fetal brain cDNA library (Negase et 
al. 2000). The human full length contains 1893 amino-acids and a 215kDa protein product 
(NP_060719.4).  CDK5RAP2 has a predicted N-terminal interaction site with the gamma-
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tubulin ring complex and two predicted structural maintenance-of-chromosomes sites 
known to be important for chromatid cohesion and DNA recombination during meiosis 
and mitosis. It also contains a Ser-rich motif for interaction with plus-end binding protein 
EB1, an interaction site with pericentrin, a C-terminal Cnn Motif 2 domain for Golgi 
complex interaction and binding to calmodulin and a C-terminal interaction site with 
CDK5R1, an activator or modulator of CDK5 (Revenkova et al. 2001; Evans et al. 2006; 
Hirano 2005; Fong et al. 2009; Wang et al. 2010; Kraemer et al. 2011).  
 Four isoforms produced by alternative splicing have been reported thus far: 
Isoform 1, (Q96SN8-1) is the full- length form; Isoform 2 (Q96SN8-2) is missing amino 
acids 702–733 (exon 19); Isoform 3 (Q96SN8-3) is missing amino acids 1009–1049 aa 
(exon 23); and Isoform 4 (Q96SN8-4) does not contain amino acids 1576–1654 (exon 32) 
(Kraemer et al. 2011). Further isoforms exist in other species as well, such as zebrafish, 
mice, rat, and others, depending on the age and organ studied (Kraemer et al. 2011).  
 
• CDK5RAP2 expression 
CDK5RAP2 is widely expressed in mouse and human tissue with high levels 
detected in the CNS during early embryonic development (Ching et al. 2000; Bond et al. 
2005; Buchman et al. 2010). Cdk5rap2 is described as the gene with slowest rate of 
evolution in MCPH genes group (Rauf and Mir, 2013), and is strongly down-regulated 
with brain maturation. Cdk5rap2 mRNA is widely expressed in human and in embryonic 
mouse tissue. There is some evidence that gene expression and/or protein isoform 
synthesis changes throughout murine brain development (Buchman et al. 2010). In 
humans, moderate to high expression was detected in all adult tissues and specific brain 
regions (thalamus, corpus callosum, substantia nigra, hippocampus and caudate nucleus) 
examined by quantitative RT-PCR ELISA with the highest levels in skeletal muscle, fetal 
liver, brain, kidney and ovary (Nagase et al. 2000; Ching et al. 2000; Bond et al. 2005).  In 
mice, Cdk5rap2 is detected in the most brain proliferative regions (Bond et al. 2005; Fong 
et al. 2008; Buchman et al. 2010). 
 
• Cdk5rap2 cellular localization 
 Cdk5rap2 has been reported to be associated with the golgi and centrosome. 
Consistent with being a centrosomal protein the subcellular localization of Cdk5rap2 
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changes during the cell cycle. Cdk5rap2 is down regulated at centrosomes during 
interphase by a microtubule-independent mechanism. CDK5RAP2 levels are increased in 
the prophase and remain high throughout mitosis until telophase, when the level drops 
again to interphase levels (Barrera et al. 2010). It has been shown that the golgi-
localization of CDK5RAP2 is dependent of centrosome function and energy supply, but 
independent of microtubules (Wang et al. 2010).  
 
• CDK5RAP2 cellular function 
 CDK5RAP2 seems to regulate several aspects of centrosome duplication in 
different species. All of which might affect cell division and lead to cell cycle arrest and 
cell death. Alternatively, the observed brain defects might have a connection to the 
regulation of cell cycle, DNA damage checkpoints, and thus proliferation and apoptosis 
(Jiang et al. 2005 and 2009). This could definitely impair tissue growth. During embryonic 
development studies it has become clear that CDK5RAP2 has an influence on brain size 
regulation. A shift in symmetric to asymmetric proliferation of progenitors may lead to a 
premature neuronal differentiation and cause brain reduction; there is a possibility that 
CDK5RAP2 is involved in cell cycle control and plays a role in regulating this shift, this is 
one of the hypothesis of MCPH phenotype caused by CDK5RAP2 (Megraw et al. 2011; 
Kraemer et al.2011; Issa et al. 2013b). 
 
Symmetric and Asymmetric Divisions 
 
There is evidence that controlling the balance of symmetric and asymmetric 
modes of division may regulate brain growth. Mouse studies revealed that when neural 
epithelia cells undergo an extra round of symmetric proliferative divisions instead of 
asymmetric mode of division significantly increased brain size (Setsuko and O’leary 2009). 
If neural epithelia cells start dividing asymmetrically from early on this will lead to the 
depletion of progenitors pool. Therefore, premature shift from symmetric to asymmetric 
neural progenitor cell divisions with a subsequent depletion of the progenitor pool and a 
reduction in the final number of neurons is one of the hypotheses believed to cause 
primary microcephalies (Megraw et al. 2011; Kraemer et al. 2011; Issa et al. 2013b). 
However evidence for this is still missing. 
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Several mechanisms such as cleavage orientation and asymmetric inheritance of 
cell fate determinants during cell division have been proposed to regulate the mode of 
cell divisions and cell fate decisions in vertebrates brain. 
 
• Cleavage orientation 
In vertebrates, the cleavage plane orientation during neural progenitors divisions is 
believed to alter neurogenesis and daughter cell fate decisions (Fish et al. 2006; Konno et 
al. 2008, Morin et al. 2011). It has been hypothesized that cleavage planes perpendicular to 
the ventricle surface, potentiate the symmetric mode divisions that generate for example 
two progenitors. While small deviations in cleavage orientation might be enough to 
disrupt the symmetric mode of divisions and promote asymmetric mode of division that 
could generate a neuron and a progenitor for example (Huttner and Kosodo, 2005; 
Zhong and Chia, 2008). Although this still needs to be proved. So far there is little 
experimental evidence supporting the role of cleavage plane orientation and modes of 
division. For example, Alexandre et al. 2010 demonstrated asymmetric divisions can result 
from perpendicular cleavage plane (Alexandre et al. 2010). Suggesting that orientation of 
cleavage planes alone might not influence the cell fate decisions in the vertebrate brain. 
 
• Asymmetric inheritance 
It is known from non-vertebrates studies that asymmetric divisions result from 
asymmetric inheritance of cell fate determinants. In vertebrates, similar mechanisms have 
been recently described. For example, asymmetric inheritance of Notch signaling 
regulator Mindbomb between the two daughters during neural progenitors division is 
dependent of the polarity protein Par3 function and might influence the fate decision 
between the two cell daughters (Dong et al. 2012). In addition, the asymmetric 
inheritance of Par3 protein and junction domain expressing ZO1 were described by 
Alexandre et al. 2010 and Konno et al. 2008, respectively, to correlate with asymmetric 
cell fate decisions. Less well understood is the asymmetric inheritance of mature 
centrosomes by the mother cell and/or stem cells while neurons inherit the young 
centrosome (Wang et al. 2009) and how centrosome could regulate cell fate decisions. 
Have been shown that a switch in Cdk5rap2 isoform expression might be specific 
to post-mitotic cells, as they persist in expression following the end of neurogenesis. It is 
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established that apical progenitors have the capacity to self-renew and maintain the 
progenitor pool during neurogenesis. In contrast, the vast majority of basal progenitors 
undergo a single terminal neurogenic division (Noctor et al. 2008). Thus, any decrease in 
the tendency of apical progenitors to undergo self-renewing divisions would be predicted 
to lead to a rapid depletion of the progenitor pool. On the other hand, an increase in the 
proportion of basal progenitors would lead to a transient increase in neuronal output. 
Cdk5rap2 knockdown alters the progenitor pool itself, decreasing the relative portion of 
apical progenitors and increasing the relative proportion of basal progenitors. This shift is 
also supported by the increase in non-surface mitoses observed following Cdk5rap2 
knockdown (Buchman et al. 2010).  
The decrease in progenitors population and premature neuronal differentiation is 
the main cause of decrease in brain size in mammalians caused by CDK5RAP2 
misfunction. However, we still are unaware whether symmetric and asymmetric modes of 
division are affected. 
 
Evolutionarily, the later cortical neuronal layers formation of mammalian cortex 
only appeared after mammals diverged from reptiles (Nieuwenhuys, 1994), and the 
formation of the superficial layers has been proposed to be primarily responsible for the 
disproportionate expansion of the cerebral cortex comparative with the mammals body 
size (Cheung et al. 2007). The essential roles of CDK5RAP2 protein in progenitor 
proliferation might reflect its relevance to the evolutionary expansion of the cerebral 
cortex (Kriegstein et al. 2006). MCPH in males are correlated with a decrease in cortical 
area, a finding that agrees with a primary effect of Cdk5rap2 knockdown on proliferation 
of radial glia (Rimol et al. 2010). 
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Animal Model 
 
Danio rerio (zebrafish) has become in the last years one of the most popular 
experimental model organisms to study the development of vertebrates. Zebrafish 
embryos have been shown to offer unraveled advantages compared to other vertebrate 
systems to study neural development and neuronal differentiation in vivo  (Clarke 2009; 
Park and Appel 2003). Zebrafish produces a large clutch of eggs; embryos develop 
externally, amenable to genetic manipulation (allows the use of antisense oligo 
morpholinos and targeted mutations using CRispr Cas9 approaches). Their transparency 
(as embryos) is the biggest reason for their attractiveness to study biological processes at 
cellular and subcellular level in vivo.  
Zebrafish embryogenesis is classified into distinct morphological stages, against 
which experimentation can be described to allow repeatable studies (figure 2). At 24 
hours post fertilization (hpf), embryos develop the organ primordia, allowing rapid 
assessment of cell fate after previous genetic manipulation (via microinjection at early 
stages of embryonic development). As a vertebrate model, zebrafish embryonic 
development is in many aspects comparable to other vertebrate models. Zebrafish 
research so far has allowed putative findings from non-vertebrates models to be 
extrapolated to other classes, with the ultimate aim of understanding the fundamental 
(and pathological) developmental mechanisms of Homo sapiens (Halbritter et al. 2013; 
Mitchison et al. 2012; Beales et al. 2007). 
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Figure 2: Timeline and Stages of Embryonic Development. The morphological staging observed 
here allows maximum reproducibility. For microinjection of morpholino, was used the one-cell stage 
embryos, this way the morpholino is homogeneously spread all over the components. For a mosaic labeling 
injection, embryos were injected in later stages, 64 – 128 cells (Kimmel et al. 1995). 
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Materials and Methods 
 
Animal care 
 
Wild type adult AB strain fish Danio rerio provided by the Institute of Child Health 
fish facility (UCL, London) were used in this study. The fishes were maintained on a 12h 
light/dark automatic cycle at 28.5°C under continuous flow of water. Fishes were feed 
with a special fish food: small granula (Special Diets Services, UK) 3 times daily and 
supplemented with brine shrimp (Interpet, UK) the night before embryo collection. For 
embryo collection, an adult male and 2 adult female fish, were placed inside one-liter fish 
tank with the inner mesh and divider. Males and females were kept in separate 
compartments during the night.  Embryos were obtained by natural breeding by removing 
the divider. On collection, embryos were kept in fish water at 28°C in a cooling incubator 
(LMS, UK)  (Westerfield et al. 2009). For some experiments, embryos were incubated at 
24 hour post-fertilization (hpf) in N-Propytthiouracie 0.2mM (Sigma-Aldrich, USA) to 
block pigmentation development. All fish were anesthetized using Tricaine (Ethyl 3-
aminobenzoat methanesulfonate, Sigma) 0.2mM. 
All experiments involving zebrafish were conducted according to the UK Home 
Office rules. The research protocols outlined here comply with internationally recognized 
guidelines for zebrafish experimentation in biomedical research. 
 
Antisense oligo-morpholinos (MO) and microinjection. 
  
To abrogate CDK5RAP2 function, we designed antisense oligo-morpholinos (MO) 
to block translation (ATG MO) and the splicing of zebrafish CDK5RAP2 between Exon 3 
and 4 (SB MO). CDK5RAP2 splice-block morpholino is predicted to retain the intron 
between Exons 3 and 4 and insert a premature STOP codon to produce protein 
truncation that would mimic one of the human mutations. As a control we designed 
Mismatch CdK5RAP2 ATG MO (MIS MO) that has 5 nucleotides substitution compared 
to the original sequence and a Standard Control MO (CMO).  
All MOs were obtained from Gene Tools, LLC, USA. The MOs were dissolved to 
4mM in sterile nuclease-free water (Life Technologies, USA) and stocks stored at -20°C. 
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For microinjection, MOs were diluted to 0.5mM (ATG MO and MIS MO), 0.6mM (SB 
MO) and 0.8mM (CMO) in nuclease-free water (Life Technologies, USA), and injected 
into one-cell stage embryos with a microinjector (Picospritzer III, Intracel, UK) with 
pressurized air aiding transport of MO from a glass needle into cell cytoplasm.  Pressure 
was calibrated in each instance to ensure drop size (measured on incremented oil drop 
slide-graticule) represented the required amount of morpholino. 
 
Cdk5rap2 MO sequences: 
• CDK5RAP2 ATG MO: 5’-TCCTCTCCGACCACAGAATCCATTC-3’.  
• CDK5RAP2 SB MO: 5’-CTGTGATTTGC TGCAAGGGAAACAT-3’).  
• Mismatch CDK5RAP2 ATG MO lower case letters indicate mismatch bases (5’-
TCCTCTaCcACCAaAGAtTaCATTC-3’)  
• Standard control MO (5’-CCTCTTACCTCAGTTACAATTTATA-3’)  
 
Embryos were then staged according to hours post-fertilization (hpf) and somite 
number (SS) (Kimmel et al., 1995). The MOs injected embryos were incubated in fish 
water at 28°C. Their embryos development was evaluated at distinctive time points 
(20hpf, 36hpf, 48hpf). 
 
 
 
 
 
 
 
 
Figure 3: Morpholino function. A) Eukaryote gene expression. B) Blocking translation by morpholino 
injection. C) Blocking splicing by morpholino injection. Image adapted from Jon D. Moulton of Gene Tools, 
LLC. 
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Whole-Mount Immunohistochemistry 
 
 Embryos injected with CMO, CDK5RAP2 ATG MO, CDK5RAP2 SB MO and 
non-injected embryos were fixed in paraformaldehyde (PFA) 4% (w/v) (Sigma-Aldrich, 
USA) in PBS (Sodium chloride 8g/l; Potassiumchloride 0.2g/l; Di-sodium hydrogen 
phosphate 1.15 g/l and Potassium dihydrogen phosphate 1.1g/l) (Thermo Scientific, UK) 
for 2h at room temperature (RT) after 20hpf, 36hpf and 48hpf.  Embryos were washed 3x 
5min in PBS  + 0.1% Tween-20 (PBT) and incubated in Blocking Solution (10% Sheep 
Serum, 0.3% Tween in 1x PBS) for 1h at RT. To enhance the primary antibody 
penetration in older embryos (36 and 48hpf), embryos were given 2 cryogenic shock 
treatments in cryogenic solution (5% Sheep serum, 8% Sucrose, 1% Tween in 1x PBS) at -
20°C, 10min each. Embryos were washed 3x 5min each, in PBT. The cryogenic treatment 
was followed by Proteinase K treatment (PK 1mg/ml in PBT) 30min at RT. Embryos were 
washed 3x 5min each, fixed in 4% PFA for 10min to inactivate the Proteinase K and 
washed 3x 5min. Embryos were then incubated with primary antibodies (see table 2) in 
Blocking solution overnight (o/n) at 4°C.  On the second day of whole-mount 
immunohistochemistry, embryos were washed 10x 10min each, in PBT to remove the 
excess of primary antibody, incubated in blocking solution for 1h at RT, and left with the 
correspondent secondary antibodies (see table 2) diluted 1:500 and DAPI (4',6-
Diamidino-2-Phenylindole) 1:10000 (Life Technologies, USA) in blocking solution o/n at 
4°C. After washing 20x 10min each, in PBT, embryos were mounted in 1.5% low-melting 
point agarose. Images were acquired in laser scan confocal microscope (Zeiss LSM 710, 
Germany) and analyzed by ImageJ software. 
 
Frozen embryo sections Immunohistochemistry  
 
Zebrafish embryos were fixed in 4% PFA in PBS for 2h. After washing in PBS, the 
embryos were cryopreserved by placing in 20% (w/v) sucrose in PBS o/n at 4°C. The 
embryos were embedded in a Mount Solution (Gelatin 7.5% / Sucrose 20% in PBS) and 
stored at -80°C. The frozen blocks were cut using a cryostat (Leica CM 1900 UV, Leica, 
Germany) into 12µm thick sections collected on SuperFrost Plus glass slides (Menzel-
Glaser, Germany). Glass slides were dried for 2h and stored at -20°C.  
 Frozen sections were thawed for 2h at RT. After hydrating the sections 3x 10min 
each, in PBT, the sections were blocked in 1% BSA, 10% Sheep Serum and 0.1% Tween-
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20 solution for 30min in a humidified atmosphere at RT. Sections were then placed o/n at 
4°C in a humidified atmosphere with primary antibodies (see table 2) in block solution. 
After several washes in PBT, slides with sections were incubated with the corresponding 
secondary antibody (1:500) (see table 2) in block solution o/n at 4°C in a humidified 
atmosphere. The nuclei were stained with DAPI (1:10000). After PBT washes, cryostat 
sections were mounted using Fluor Save Reagent mounting medium (Calbiochem, 
Germany) with coverslip (Scientific Laboratory Supplies LTD, UK). Image acquisition 
occurred on a laser scanning confocal microscope (Zeiss LSM 710, Germany) and Images 
were later analyzed with ImageJ free software. 
 
Table 2 – Antibodies used in immunofluorescence labeling 
Antibody Species Supplier  Dilution used 
Primary antibodies    
Anti - ZO-1 Mouse Life Technologies, 
USA 
1:300 
Anti - HuC/D Mouse Life Technologies, 
USA 
 
1:200 
Anti - aPKC Rabbit  Santa Cruz 
Biotechnology 
1:300 
Anti – PH3 Mouse Milipore 1:2000 
Secondary 
antibodies 
   
Alexa Fluor® 568 
anti-mouse IgG 
Rabbit  Life Technologies, 
USA 
1:500 
Alexa Fluor® 488 
anti-rabbit IgG 
Mouse Life Technologies, 
USA 
1:500 
Alexa Fluor® 488 
anti-sheep IgG 
Rabbit   Life Technologies, 
USA 
1:500 
Alexa Fluor® 488 
anti-mouse IgG 
Mouse Life Technologies, 
USA 
1:500 
ZO-1, Zona occludens-1. HuC/D, Elav family members HuC, HuD and Hel-N1 neuronal proteins. 
aPKC, Atypical protein Kinase C. PH3, P hosphohistone-H3. 
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Probe synthesis and In-situ Hybridization. 
 
To determine the expression pattern of Cdk5rap2 mRNA in zebrafish, two 
distinct probes (P1 and P2) were synthesized. The primers sequence can be found in 
Table 3. cDNAs fragments corresponding to P1 and P2 Cdk5rap2 in situ hybridization 
probes have been amplified by Polymerase chain reaction (PCR) from a cDNA library of 
24hpf zebrafish. PCR amplified products were run on 1% Agarose Gel by electrophoresis. 
Bands corresponding to 400 base pairs (bp) were cut from the gel and DNA purified 
using a Qiagen gel extraction kit. DNA concentration was measured on the Nanodrop 
(Thermo scientific, USA). DNA fragments were cloned by T/A cloning into an expression 
vector (PROMEGA pGEM-T Vector systems). Ligation occurred o/n at 4°C. Ligation 
products were transformed into XL10 bacteria by heat-shock. Transformed bacteria 
were then plated in LB agar plates with ampicillin. Colonies of ampicillin resistant bacteria 
were growth overnight in LB medium plus ampicilin at 37°C. Plasmids were purified using 
Miniprep kit (Qiagen, USA). Cdk5rap2 P1 and P2, antisense and sense were synthesized 
using RNA DIG labeling probes. 
24hpf embryos were fixed in 4% PFA o/n at 4°C. Embryos were washed in PBT 3x 
10min each, and dehydrated progressively in Methanol. Embryos were stored in 100% 
Methanol at -20°C. For in situ hybridization, embryos were re-hydrated with 75%, 50% 
and 25% Methanol/PBT solutions, 5min each. They were washed 4x 5min each and 
incubated with Hyb Mix solution (50% Formamide, 1.3x SSC20x, 5mM EDTA, 50µg/ml 
Yeast RNA, 0.2% Tween-20 and 100µg/ml Heparin in water) for 30min at RT, and then 
1h at 67ºC. Embryos were incubated with P1 and P2 sense and antisense probes over-
night, 0.5; 1 or 1.5ng/µl in hybridization solution, at temperatures tested ranging from 55 
to 67°C.  
On the second day of in situ hybridazation the excess of unbound RNA probe was 
washed away by successive washes of formamide based solutions at high temperatures. 
Embryos were then incubated o/n at 4°C with anti digoxigenin antibody coupled to 
Alkaline phosphatase. On the third day of in situ, the excess of antibody was washed away 
with 1x MABT buffer (0.1M maleic acid, 150mM NaCl and 0.1% Tween-20). Finally, 
embryos were incubated for 10min in an alkaline solution suitable for Alkaline 
Phosphatase (AP) functioning (pH 8.5). Alkaline Phosphatase converts NBT/BCIP 
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substract into a blue precipitate. This precipitate will stain cells that contain RNA DIG 
labeled probes. 
Table 3 – Primers sequence and melting temperature (mT). 
Oligo Name Sequence mT ºC 
Cdk5rap2 P1 
Forward 
5´-GCAGATTGGAGCAGAAAACC 63.7 
Cdk5rap2 P1 
Reverse 
5´-GTTGCTCCAGCTCTTGTTCC 63.4 
Cdk5rap2 P2 
Forward 
5´-GCCTTGGATGAGAAGTTTGC 63.7 
Cdk5rap2 P2 
Reverse 
5´-GCTGATCTTTGCTGTGATG 63.7 
 
 
Embryos Imaging  
 
For live-imaging, embryos were injected with mRNAs coding for fluorescent 
tagged proteins such as membrane fused to Green or Red Fluorescent protein (GFP or 
RFP) at 1 to 64 cells stage. Embryos were left to grow at 28°C until they reached 24hpf. 
At this point embryos were manually dechorionated. Detection of adequate fluorescence 
was assessed using a lower power light microscope with fluorescent filters. Where 
appropriate, embryos were segregated by phenotypic severity under light microscopy. 
Embryos were treated with N-Propytthiouracie 0.2mM to prevent development of 
pigmentation and they were anesthetized in Tricaine (0.2mM) to block their movements. 
Embryos were then mounted in 1% low melting-point agarose (Sigma) in a small 
microscope petri dish with frontal aspect of telencephalon facing down. Images were 
obtained using 40x water-immersion objectives in Zeiss LSM 710 laser scan confocal 
microscope. During imaging embryos were maintained at 28°C in fish water containing N-
Propytthiouracie and Tricaine (Tawk et al, 2007, Alexandre et al. 2010). To produce 
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detailed time-lapse movies series of Z-stacks, 2.50µm apart, were captured every 5min 
for several hours (Tawk et al. 2007, Alexandre et al. 2010).  
Zebrafish embryos labeled by immuno-histochemistry, were mounted in low-
melting point agarose as described above, maintained in 1x PBS and imaged in Zeiss LSM 
710 confocal microscope with 40x water-immersion objective.  Z-stacks, 2.50µm apart, 
were captured in series down the front-caudal axis to generate digital reconstructions. 
To measure brain size, embryos were anaesthetized with Tricaine (0.2mM) and 
immobilized in 1% low melting-point agarose (Sigma). Images were taken from lateral view 
using a dissecting scope and camera Leica DFC490. 
 
Image analysis  
 
To build and analyze the time-lapses images, count the total number of neurons 
and progenitors in telencephalon and measure brain sizes, images were analyzed in free 
software ImageJ and FiJi. 
 
Statistical treatment. 
 
Images were exported from Zeiss LSM 710 confocal microscopy software as lsm 
format files and stacked/analysed using ImageJ, to generate data. These data were then 
analysed using graphical and statistical functions in Microsoft Excel, GraphPad Prism and 
SigmaStat.  
Once raw data was collated from defining and counting mitotic positions and 
neuronal and progenitor cells in zebrafish telencephalon, they were exported from 
Microsoft Excel into Graphpad Prism and Sigma Stat for statistical analysis.
	  	  	  
	  	  	  
 
 
 
 
 
 
 
 
Chapter III 
 
	  	  	  
Results 	  
27	  	  
Results 
 
Cdk5rap2 gene expression in zebrafish embryos. 
 
Cdk5rap2 is expressed in human and mouse CNS (Buchman et al. 2010; Ching et 
al., 2000). To determine the mRNA expression pattern of Cdk5rap2 in zebrafish embryos, 
a whole mount in situ hybridization has been performed in 24hpf zebrafish embryos. Two 
distinct antisense mRNA in situ probes were designed for the N-terminal region of 
zCdk5rap2. Unfortunately, both probes were non-specific. Different hybridisation 
temperatures and probe concentrations were used with no success. Some examples can 
be observed in figure 2.  Future plans include new probes design around the C-terminal of 
zCdk5rap2. 
 
 
Figure 4: Non-specific detection of zCDK5RAP2 mRNA expression by in situ hybridization. 
Lateral view of 24hpf zebrafish embryos. In situ hybridisation was performed in zebrafish embryos with two 
different probes by in situ hybridisation technique (A – anti-sense designed probe; B – sense designed 
probe). The detection revealed non-regionalised patterns of zCdk5rap2 mRNA expression typical for non-
specific probes. The images were obtained under dissecting scope and camera Leica DFC490 with 4X 
magnification. 
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Microcephaly in zebrafish embryos is induced by injection of 
CDK5RAP2 antisense oligo-morpholinos. 
 
Cdk5rap2 misfunctions have been associated with human microcephalies and small 
brain phenotypes (Woods et al. 2005). In order to understand the role of CDK5RAP2 on 
brain size, CDK5RAP2 antisense translation-block (ATG MO) and splice-block (SB MO) 
oligo-morpholinos were injected in one-cell stage zebrafish embryos. Brain sizes, length 
and width, were measured at 2 days post-fertilization (dpf) and 5dpf (figure 5).  
 
 
 
 
Figure 5: CDK5RAP2 morpholino injection produces small brain phenotypes. Lateral view of 
non-injected (on top), translation-block morpholino injected zebrafish embryo (on bottom left) and splice-
block morpholino injected zebrafish embryo (on bottom right). Red and green lines represent brain width 
and length, respectively. Images representative of CDK5RAP2 translation-block (ATG MO) and splice-block 
(SB MO) morpholino injection experiments. Scale bar: 20 µm. 
 
 
 
Injection of CDK5RAP2 translation-block antisense oligo (ATG MO) is predicted 
to reduce the translation of the coding region of the targeted Cdk5rap2 gene and to 
induce microcephalic phenotype in zebrafish embryos.  
We observed that both translation-block and splice-block antisense morpholinos 
(ATG MO and SB MO) induce microcephalic phenotype in zebrafish embryos when 
compared to the control groups (figure 6 and 7). No significant differences in brain size 
were detected between the control groups (non-injected and standard control 
morpholino injected embryos). This suggests that morpholino injection on one-cell stage 
embryos does not promote a decrease on the brain size.  
The CDK5RAP2 translation-block morpholino exerts a dose dependent effect on 
the brain growth (figure 6). Microcephalic phenotypes produced by lower concentrations 
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of translation-block morpholino are rescued by 5dpf (figure 6D), which can be explained 
by the earlier depletion of antisense morpholino. In most experimental conditions 
undertaken, zebrafish embryonic brain grew between the 2nd and 5thdpf, however, higher 
concentrations of CDK5RAP2 translation-block morpholino lead to brain growth arrest. 
This indicates that higher concentrations of morpholino can efficiently block brain 
development. The CDK5RAP2 translation-block morpholino also show a dose dependent 
way in brain effects (figure 6). 
 
 
Figure 6: Zebrafish embryos injected with CDK5RAP2 translation-block antisense morpholino 
have smaller brains.  Brain length (A, B) and width (C, D) of non-injected and Control Morpholino 
(CMO) with Translation-block Morpholino (ATG MO) 2dpf (A, C) and 5dpf (B, D) zebrafish embryos. (A, 
B, C, D) ATG MO injection significantly decreases brain sizes at 2dpf and 5dpf compared to the non-
injected and CMO with similar ages. In A) or B) the injection of 0.5pg of translation-block morpholino 
significantly decreased brain size when compared with the embryos injected with 0.38pg. Asterisks in black 
compare brain sizes of non-injected embryos with ATG MO injected embryos while brown asterisks 
compare CMO injected embryos and purple stars analyses compare to the embryos injected with 0.38pg of 
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ATG MO. Two way ANOVA of group’s length and width, followed by Holm-Sidak multiple comparison 
post test, *p<0.05; **p<0.01; ***p<0.005 and ****p<0.001.  
 
 
Figure 7: Brain size decreases with CDK5RAP2 splice-block MO injection in zebrafish 
embryos. Brain length and width at 2dpf of: Control Morpholino (CMO) and Splice-block Morpholino (SB 
MO) injected zebrafish embryos. SB MO injection also significantly decreases the length and width of brain 
of zebrafish embryos. The brown stars are the analyses compare to the CMO injected embryos. One way 
ANOVA of groups; length followed by Holm-Sidak’s multiple comparison test, and width followed with 
kruskal-wallis and Dunn’s multiple comparison post test ****p<0.001. 
 
The zCDK5RAP2 splice-block morpholino (SB MO) was designed to create a 
truncated protein that mimics Cdk5rap2 mutations found in humans. Splice-block 
morpholinos interfere with pre-mRNA processing stages and prevent splicing by blocking 
the splice-directing small nuclear ribonucleoproteins complexes from binding to their 
targets at the borders of introns on a strand of pre-mRNA.  
These morpholino injection experiments revealed that both splice-block and 
translation-block morpholinos affects brain development and growth. However, these 
observations have to be confirmed by validating morpholino function and producing a 
zebrafish Cdk5rap2 mutant. 
We tried to validate translation-block MO function and specificity by injecting a 
five base mismatch morpholino (MIS MO) predicted not to recognize the target sequence 
neither have an effect in brain development. However, mismatch MO injected embryos 
presented a more severe microcephaly than embryos injected with translation-block 
morpholino (figure 8). The MIS MO decreased the width of brain size similar to higher 
concentration of translation-block morpholino (p<0.05) (figure 8). Later at 5dpf, the 
translation-block morpholino starts losing the effect, while mismatch morpholino still 
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reduce width of brain size (p<0.001). All embryos injected with higher concentrations of 
mismatch morpholino did not develop until 5dpf (figure 8). These unexpected 
observations demonstrated that mismatch MO may still recognise the target RNA or this 
morpholino may be non-specific and recognise multiple target sequences. In future, we 
will distinguish between these two possibilities by rescuing morpholino effects with the 
injection of zCdk5rap2 mRNA. 
 
 
Figure 8: Cdk5rap2 Mismatch Morpholino promotes a severe microcephalic phenotype. 
Zebrafish embryos were analysed in different groups: Non-injected, Translation-block (ATG MO) and 
Mismatch Morpholino (MIS MO) injected at different concentrations. A) Brain length of zebrafish embryos, 
at 2dpf. ATG MO and MIS MO injections significantly decrease brain length at 2dpf. B) Brain length of 
zebrafish embryos, at 5dpf. The higher concentrations of ATG MO significantly decrease brain length at 
5dpf compare with the lower concentration of 0.25pg and with non-injected embryos. MIS MO injection 
significantly decreases the brain lengths at 5dpf when compared to the non-injected embryos. C) Brain 
width of zebrafish embryos, at 2dpf. ATG MO injection (0.38 and 0.5pg) significantly decreases the brain 
width when compared with non-injected embryos. MIS MO significantly decreases brain width when 
compared with non-injected embryos. D) Brain width of zebrafish embryos, at 5dpf. MIS MO significantly 
decreases brain width when compared with all the other conditions. The embryos injected with 0.5pg of 
MIS MO did not develop until 5dpf. The black stars analyses compare to the non-injected embryos, brown 
stars analyses compare to the CMO injected embryos; purple stars analyses compare to the embryos 
injected with 0.38pg of ATG MO; orange stars analyses compare to the embryos injected with 0.5pg of 
ATG MO. Statistical significant difference was analysed by One way ANOVA of group’s width at 2dpf (with 
****! ****!
***!
A! B!Length 2 dpf! Length 5 dpf!
****! ****! ****! ****!
****!
§§§§!
µm
 !
µm
 !
Non-
injected!
0.38pg!0.5pg!0.25pg!
ATG MO!
0.38pg!0.5pg!0.25pg!
MIS MO!
Non-
injected!
0.38pg! 0.5pg!0.25pg!
ATG MO!
0.38pg!0.25pg!
MIS MO!
Non-
injected!
0.38pg!0.5pg!0.25pg!
ATG MO!
0.38pg!0.5pg!0.25pg!
MIS MO!
Non-
injected!
0.38pg! 0.5pg!0.25pg!
ATG MO!
0.38pg!0.25pg!
MIS MO!
C! D!Width 2 dpf! Width 5 dpf!
****!****! ****! ****! ****! ****!****!
****!
****!
µm
 !
µm
 !
****!****!
****!
****!
****!****!
****!
****!
****!****!
****!
****!
Results 	  
32	  	  
Kruskal-Wallis and Dunn’s method); width at 5dpf (with Holm-Sidak’s method); length at 2dpf (with Holm-
Sidak’s method); width at 5dpf (with Kruskal-Wallis and Dunn’s method) ***p<0.005 and §§§§ or 
****p<0.001. 
 
The concentration of 0.6pg of control and splice-block morpholinos, and 0.5pg of 
translation-block morpholino were chosen for the following experiments. These 
morpholinos show a dose dependent phenotype and these concentrations led to a small 
brain phenotype (translation-block and splice-block morpholino) with less or no tissue 
death (grey appearance) visible under the microscope. 
 
Apoptotic cell death does not explain the small brain phenotype 
caused by the injection of antisense oligo-morpholinos. 
 
With a gross observation of tissue grey discoloration of cells, an increase in cell 
death was observed with increasing concentrations of antisense oligos morpholinos. In 
order to investigate whether small brain phenotypes could be induced by an increase in 
apoptotic cell death, we used acridine orange a nucleic acid-selective metachromatic stain 
that stains death cells. (Yuan et al. 2014) 
After the morpholino injection, embryos were stained, imaged and analysed. An 
increase in acridine orange labelling was observed on both control and splice-block 
morpholino injected embryos when compared to non-injected embryos (figure 9). The 
cell death is generally associated to the injection of oligonucleotides. 
To investigate whether the increase in cell death could explain the microcephalic 
phenotype caused by CDK5RAP2 morpholino injection we injected translation-block 
morpholino in p53-/- mutant background embryos. The p53 knockout zebrafish mutant is 
known to have inhibited apoptotic cell death. 
Following morpholino injection, embryos were imaged and head length/width 
were measured and compared with control embryos. As shown in figure 8, CDK5RAP2 
injected p53-/- embryos had both significantly reduced head length and width when 
compared with control morpholino injected p53-/- embryos (p<0.0001) (figure 10). 
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Figure 9: Cell death by acridine orange staining does not increase with morpholinos injection. 
Acridine orange staining (green) on telencephalon of zebrafish embryos (non-injected and control 
morpholino or splice-block morpholino injected embryos) at 24hpf. Scale bar: 20 µm. 
 
Aside from the reduced head size, no other significant phenotypic features were 
noted. This suggests that microcephalies induced by CDK5RAP2 morpholino do not 
result from an increase in apoptosis.   
Although it is not possible to rule out the role of other cell death pathways in 
microcephaly from these results alone, it is possible to state that the role of p53-related 
apoptosis, a major cell death pathway, is not relevant for the microcephalic phenotype. 
Investigations into the role of CDK5RAP2 abrogation in microcephaly were continued 
with the knowledge that incidences of apoptosis were not part of any underlying 
mechanisms. 
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Figure 10: Brain size remains decreased with translation-block morpholino injection. A) Lateral 
view of representative zebrafish, Control morpholino (CMO) and Translation-block morpholino (ATG MO) 
in p53-/- background at 2dpf. B) Brain length and width at 2dpf of: CMO and ATG MO injected zebrafish 
embryos. ATG MO injection decreases significantly the length and width of brain of zebrafish embryos. 
Stastistical significant difference was analysed by Unpaired two-tail t-test: *** p<0.001. 
 
 
Epithelia cell polarity is not altered in embryos injected with 
CDK5RAP2 translation-block morpholino. 
 
The neuronal progenitor division happens mainly at the apical surface and soon 
after the division daughter cell reform apical and basal attachments to the apical and basal 
surfaces. Apical cell polarity is important in determining the mode of neural progenitors 
division (symmetric and asymmetric) that occurs at the apical surface of the 
neuroepithelium (Alexandre et al, 2010; Huttner and Kosodo, 2005). 
In order to test whether a decrease in growth caused by CDK5RAP2 MO 
injection depends on the apical polarity protein malfunction, we detected aPKC and ZO1 
(polarity markers) by immunostaining in control and CDK5RAP2 morpholino injected 
embryos. We found no differences between CDK5RAP2 and control morpholino injected 
embryos, suggesting that microcephalies induced by translation-block morpholino do not 
result from apical proteins mislocalisation (figure 11).  
This suggests that apical polarity remains unaffected and that the microcephalic 
phenotype may be induced by other molecular mechanisms. 
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Figure 11: Apical polarity markers are present in embryos injected with translation-block 
morpholino. Nucleus stained with DAPI (green) and the apical polarity stained with aPKC and ZO-1 
antibodies (red). Dorsal (aPKC) and transversal (ZO-1) views of zebrafish hindbrain at 24hpf. Control 
morpholino (on left column) and translation-block morpholino (on right column) demonstrated that both 
polarity markers are present in embryos injected with CDK5RAP2 morpholino. Scale bar: 20 µm. 
 
CDK5RAP2 morpholino injection decreases neurogenesis rate 
(N/P) in zebrafish embryos. 
 
Our work suggests that cell death and cell polarity were unlikely the causes of 
small brain phenotypes observed in zebrafish embryos injected with CDK5RAP2 
antisense oligo morpholinos. It has been shown in mammalian systems that CDK5RAP2 
promotes premature neuronal differentiation and premature depletion of stem cell 
populations. To determine the rate of neurogenesis, zebrafish embryos were injected 
with control morpholino and CDK5RAP2 morpholinos (translation-block morpholino and 
splice-block morpholino). We distinguished neurons and progenitors by performing 
HuC/D antibody staining and counterstaining with DAPI. To determine if CDK5RAP2 
regulates neurogenesis, we counted the total number of neurons (N) (HUC/D positive) 
and progenitors (P) (HUC/D negative) in telencephalon and analysed the neurogenesis 
rates (N/P) in control and experimental embryos (figure 12A).  
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Figure 12: Neurogenesis (N/P ratio) decreases with injection of Cdk5rap2 splice-block 
morpholino. Neurogenesis rates (N/P ratio) in control, translation-block and splice-block morpholino 
injected zebrafish embryos at 20, 36, 48hpf.  A, B) The neurogenesis was quantified on zebrafish 
telencephalon counting the neurons (N) labelled with HuC/D antibody (green) and the progenitors (P) 
labelled only with DAPI (blue). A) Optical section of zebrafish telencephalon with all nuclei stained with 
DAPI (blue) and neurons expressing HuC/D (green). B) Neurogenesis increased from the early to late 
stages of embryonic development.  In embryos injected with splice-block morpholino, neurogenesis 
significantly decreased when compare with non-injected and control morpholino injected embryos **** 
p<0.001. Statistical significant difference was analysed by One-Way ANOVA followed by Holm-Sidak 
multiple comparison post test. Scale bar: 20 µm. 
 
 
We observed that during zebrafish embryonic development (from 19 somites (ss) 
to 48hpf) neurogenesis increased in telencephalon in all experimental conditions. In 
embryos injected with splice-block morpholino, neurogenesis is significantly reduced at 
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36hpf when compared to the control conditions (figure 12B) (p<0.001). This observation 
is surprising and contradicts previous mammalian data that suggested microcephalic 
phenotypes are due to an increase in neuronal differentiation at early stages of embryonic 
development (these mechanisms have been thoroughly reviewed Kraemer et al. 2011 and 
Megraw et al. 2011). Our data also reveals that CDK5RAP2 splice-block morpholino has a 
stronger effect than translation-block morpholino to decrease neurogenesis.  
 
Injection of CDK5RAP2 morpholinos decrease the total number of 
progenitor divisions. 	  
To determine whether cell proliferation is affected in CDK5RAP2 morpholino 
injected embryos and whether this could explain the unexpected reduction in 
neurogenesis, we counted the number of dividing cells in mitosis phase (labelled by P-
Histone 3 antibody staining) at the apical and basal surfaces of neural epithelium.  
Injection of translation-block morpholino showed a significant decrease on the 
proportion of apical divisions in zebrafish embryos at 36hpf when compared to control 
embryos (p<0.001).  Zebrafish embryos injected with splice-block morpholino showed a 
similar reduction on the proportion of apical divisions at earlier (19SS) stages of 
embryonic development when compared to the control (p≤0.005). However, splice-
block morpholino injected embryos later showed (at 48hpf) an increase in basal divisions 
(p<0.01) (figure 13). All together this data suggests that apical divisions tend to decrease 
in embryos injected with CDK5RAP2 morpholinos. We also observed that at 48hpf there 
was a significant increase on the proportion of basal divisions in embryos injected with 
ATG morpholino when compared to the control cases (p<0.001). However, these 
divisions are in very low number (1 in 15) and therefore the alterations in this population 
of progenitors are very difficult to address.  
Our data suggests that the decrease on the proportion of cell divisions might 
depend on cell numbers that are reduced. This suggests that alternative mechanisms such 
as cell cycle arrest or an increase of cell cycle length may account for the decrease in 
neuronal populations and small brain phenotypes.  
At the later stages of embryonic development, in embryos injected with 
CDK5RAP2 MO the proportion of cells in proliferation appears to catch up with wild 
type embryos (figure 14). Zebrafish brain is highly proliferative and from our results it 
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seems to be recovering either from a possible cell cycle arrest or an increase of cell cycle 
length during early stages. 
 
Figure 13: Injection of CDK5RAP2 morpholinos decreases the proportion of mitosis. The 
number of cells in mitosis, pH3 positive, in all telencephalon of control and CDK5RAP2 morpholinos 
injected embryos was determined. Embryos injected with splice-block morpholino had a significant decrease 
on the proportion of apical divisions at 19 somite’s stage embryos. Embryos injected with translation-block 
morpholino showed a significant decrease on the proportion of apical divisions in 36hpf and an increase in 
basal divisions at 48hpf embryos when compared to control embryos. Statistical significant difference was 
analysed by two way ANOVA followed by Holm-Sidak multiple comparison post test; ***p<0.005 and 
****p<0.001. 
 
 
 
 
Figure 14: Rescue or natural catch up of proliferation at later stages. At the later stages of 
development a rescue appear to start or a natural catch up of cell proliferation is observed at 36hpf till 
48hpf. Zebrafish is known as a higher proliferative system and it seems to be recovering from a possible 
disruption of cell proliferation caused by CDK5RAP2 morpholinos injection. 
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Validation of CDK5RAP2 morpholino and antibody. 
 
To validate CDK5RAP2 morpholinos functions, we tested a customer-made 
antibody against zebrafish CDK5RAP2 by Western blot. The zCDK5RAP2 protein is 
predicted to have two isoforms, one with 300kDa and the other with 150kDa. However, 
this antibody recognized bands corresponding to 5 different sizes. Three of them 
(300kDa, 150kDa and 100kDa) were faint when we injected CDK5RAP2 splice-block 
morpholino but not translation-block morpholino (figure 15). To confirm that these three 
bands truly correspond to zCdk5rap2, we performed Mass Spectrometry analyses and we 
are still awaiting the results. 
Unfortunately translation-block morpholino did not have any effects in bands intensity 
suggesting that this morpholino it may be non-specific. This also reveals the importance 
to repeat some of our initial experiments with antisense oligo splice-block morpholino 
and urgently produce a Crispr/Cas9 mutant to validate our current observations. 
 
 
Figure 15: CDK5RAP2 decrease in zebrafish embryos injected 
with splice-block morpholino. We observed by western blot analysis 
of custom-made antibody against zebrafish CDK5RAP2 recognizes 5 
bands; and two of them have the predicted size for zebrafish CDK5RAP2 
(300 and 150kDa) (blue square). The staining confirms a decrease on 
CDK5RAP2 expression when we injected with splice-block morpholino 
but not translation-block morpholino. 
 
 
 
 
In summary, CDK5RAP2 morpholino injection, induce a small brain phenotype 
during the embryonic development. However, this microcephalic phenotype is not caused 
by an increase of cell death or disruption of polarity proteins.  
Neurogenesis and cell proliferation might be decreased with CDK5RAP2 
morpholino. This could be caused by either an increase of cells in cell cycle arrest or cell 
cycle length.  
 Although the validation of our zCDK5RAP2 antibody is still in progress and we 
are not able to confirm the specificity of our antibody. In order to confirm all our 
achievements a Cdk5rap2 mutant background is being produced. 
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Discussion 
 
The major focus for this project was to understand the function of Cdk5rap2 in 
the development of zebrafish telencephalon. In microcephaly studies, it is suggested that 
Cdk5rap2 influences brain size during development (Woods et al. 2005). Zebrafish is a 
well-characterized model which is particularly useful in studies involving genetics and 
cellular biology due to its genetics, transparency and easy visualization of deep tissue. In 
the same way as c. elegans, drosophila and cell culture, zebrafish is a good model to analyze 
gene function and theoretically, to understand the origin of MCPH3. Using this model, 
this study revealed that CDK5RAP 2 abrogation disrupts the brain size by preventing cell 
proliferation, which go against the previous findings in mammalian systems thought to 
increase neurogenesis. 
 
To validate these observations and correctly gauge the impact of the decrease in 
Cdk5rap2 function, we used CDK5RAP2 morpholino injected cells and transplantation 
approaches to analyzed the expression of gamma-tubulin around the centrosome and cell 
behaviours. If we had more time, this transplantation approach would have allowed us to 
compare progenitors depleted of Cdk5rap2, integrated close to wild-type progenitors in 
the same embryo. Given that the intensities of immunofluorescence greatly varied 
between samples, the ability to detect differences of gamma-tubulin in wild type and 
CDK5RAP2 morpholino injected progenitors in the same embryo would have overcome 
this problem. Unfortunately, using this technique did not allow us to confidently detect 
differences in gamma-tubulin intensities, or in cell behaviour. Gamma-tubulin intensities 
varied depending on the phase of cell cycle, while embryos prepared for live-imaging 
encountered problems of embryo misorientation and wrong age. This cell transplantation 
approach could also be used to show that cell polarity in CDK5RAP2 morpholino 
injected embryos are intact.  
 
We were unable to detect Cdk5rap2 mRNA expression by in situ hybridization 
with two distinct probes. After several attempts of optimization of the protocol and 
preparation of solutions, the in situ hybridization worked for the control probe Her4 but 
not for Cdk5rap2. There could have been an issue with probes specificity. New in situ 
hybridization probes in C-terminal region of CDK5RAP2 sequence should be designed. 
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Our data obtained with injection of morpholinos supports the findings obtained in 
mammalian systems where the loss of CDK5RAP2 function results in a decrease in brain 
size. However, our results contradicts the mammalian data, in the sense that knockdown 
of Cdk5rap2 in zebrafish resulted in a decrease in neurogenesis and decrease of cells in 
proliferation. To prove that zebrafish microcephalies may be caused by different 
molecular mechanism that the one described in mammalian system, we will produce and 
confirm these observations using Cdk5rap2 mutant. 
 
It has been shown that a 24-hour delay in the switch from symmetric divisions to 
asymmetric divisions leads to an increased in proportion of progenitors in mice. The 
seemingly minor alteration leads to a significant increase in brain size of affected mice 
(Setsuko and O’Leary 2009). Taking this into account, it is an absolute requirement in the 
microcephaly field to demonstrate that microcephalies result from the disruption of 
symmetric mode of divisions.  Using the zebrafish as a model it would be possible to 
follow the behavior of individual neural progenitors at the neuroepithelium by doing live 
imaging as described in Alexandre et al (2010). This would allow observation and 
quantification of changes in the proportion of symmetric and asymmetric division or the 
number of cells moving to the basal surface or cell cycle arrest. Our ultimate goal is to 
demonstrate for the first time that cell fates are altered in Cdk5rap2 mutants and 
morpholino injected embryos by following early cell divisions and cell fate decisions in 
vivo.  
 
We also observed a decrease in the total number of cell divisions, which may be 
due to either an increase in cell cycle arrest or cell cycle length. To determine which one 
may be happening, we could use cell cycle markers such as, PCNA-GFP that labels 
transition between G2 and M (Leung et al. 2011) or FUCCI line (which is a zebrafish Fucci 
system), which would permit us to determine the proportion of progenitors in different 
phases of cell cycle in wild type and compare it to mutants (Bouldin and Kimelman (2014). 
This would establish whether Cdkrap2 knockdown could lead to progenitor pool 
depletion by driving neural progenitors toward terminal neurogenic divisions as a result of 
increased cell cycle length (Buchman et al. 2010). To this end, more experiments should 
be conducted to consider the hypothesis of disruption in cell cycle. 
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We were disappointed with morpholino technology and to discover that 
mismatch morpholino used to validate the function of translation-block morpholino does 
not work. This morpholino with 5-mismatched base pairs should not recognize the 
targeted sequence and should prevent CDK5RAP2 protein translation. However, the 
injection of the mismatch morpholino gave us the same microcephalic phenotype as well 
as the translation-block morpholino. This indicates two things, either that mismatch 
morpholino recognizes the targeted sequence or that this morpholino is non-specific.  In 
order to validate the function of translation-block morpholino we will have to rescue its 
function by injecting the full length of mRNA. 
 
It would also be interesting to investigate the extent to which divisions need to be 
disrupted for a microcephalic phenotype to occur. It therefore seems logical to 
determine whether a premature switch in division mode leads to a decrease in brain size 
and the extent to which this prematurity must occur to cause a significant alteration in 
cortical size.  
 
Manifestation of microcephaly in MCPH patients is established during embryonic 
growth with a head circumference that is below average (Woods et al. 2005). The 
majority of MCPH patients do not exhibit severe growth defects.  Primary microcephaly 
is the most notable common feature of these diseases. Our data complement current 
hypotheses about the origins of MCPH that a defect in neural progenitor proliferation can 
account for the manifestation of primary microcephaly  (Bond and Woods, 2006; Fish et 
al. 2006; Woods et al. 2005). We optimized that the injection of CDK5RAP2 
morpholinos at early time points during neurogenesis in the telencephalon is a suitable 
strategy for the study of MCPH3 as it allows us to target the cell population thought to 
be most involved in the manifestation of MCPH within the most severely affected region 
of the CNS. However, the Cdk5rap2 mutant background shall be the best model to 
investigate the effects of Cdk5rap2 knockdown and accurately determine the role of 
Cdk5rap2 in MCPH research. 
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Conclusions 
 
The results obtained in this work have shown that Cdk5rap2 plays an important 
role in brain growth in the zebrafish. Reduction of Cdk5rap2 function results in a 
microcephalic brain phenotype with an increase in neurogenesis and a reduction of cells 
in division. These findings imply that Cdk5rap2 is essential to restrict the normal 
development in zebrafish brain. This observation suggests that CDK5RAP2 is fundamental 
for maintenance of many properties of cell division. Further studies are needed to 
confirm the present conclusions. 
 
	  	  	  
	  	  	  
 
 
 
 
 
 
 
 
 
 
 
Chapter VI 
	  	  	  
References 	  
53	  	  
References 
 
• ALEXANDRE, P.; REUGELS, A. M.; BARKER, D.; BLANC, E.; and CLARKE, J. D. 
W. - Neurons derive from the more apical daughter in asymmetric divisions in the 
zebrafish neural tube. Nature Neuroscience, 13(6) (2010) 673-680 
• BARRERA, J. A.; KAO, L. R.; HAMMER, R. E.; SEEMANN, J.; FUCHS, J. L.; 
MEGRAW, T. L. - CDK5RAP2 regulates centriole engagement and cohesion in 
mice. Dev. Cell., 18(6) (2010) 913–926 
• BEALES, P. L.; BLAND, E.; TOBIN, J. L.; BACCHELLI, C.; TUYSUZ, B.; HILL, J.; 
RIX, S.; PEARSON, C. G.; KAI, M.; HARTLEY, J.; JOHNSON, C.; IRVING, M,; 
ELCIOGLU, N.; WINEY, M.; TADA, M.; SCAMBLER, P. J. - IFT80, which encodes 
a conserved intraflagellar transport protein, is mutated in Jeune asphyxiating 
thoracic dystrophy. Nat Genet. 39 (2007) 727-9 
• BOND, J. and WOODS, C. G. – Cytpskeletal genes regulating brain size. Curr. 
Opin. Cell. Biol. 18 (2006) 95-101 
• BOND, J.; ROBERTS, E.; SPRINGELL, K.; LIZARRAGA, S. B.; SCOTT, S.; 
HIGGINS, J.; HAMPSHIRE, D. J.; MORRISON, E. E.; LEAL, G. F.; SILVA, E. O.; 
COSTA, S. M.; BARALLE, D.; RAPONI, M.; KARBANI, G.; RASHID, Y.; JAFRI, H.; 
BENNETT, C.; CORRY, P.; WALSH, C. A.; WOODS, C. G. - A centrosomal 
mechanism involving CDK5RAP2 and CENPJ controls brain size. Nat. Genet., 37 
(2005) 353–355 
• BOULDIN, C. M. and KIMELMAN, D. – Dual Ducci: A new transgenic line for 
studying the cell cycle from embryos to adults. Zebrafish 11 (2014) 182-183 
• BUCHMAN, J. J.; TSENG, H. C.; ZHOU, Y.; FRANK, C. L.; XIE, Z.; TSAI, L. H. - 
Cdk5rap2 interacts with pericentrin to maintain the neural progenitor pool in the 
developing neocortex. Neuron, 66(3) (2010) 386– 402 
• CHAVALI, P. L.; PUTZ, M.; GERGELY, F. - Small organelle, big responsibility: the 
role of centrosomes in development and disease. Philos Trans R Soc Lond B Biol 
Sci. 369 (2014) 
• CHEUNG, A. F.; POLLEN, A. A.; TAVARE, A.; DePROTO, J. and MOLNAR, Z. - 
Comparative aspects of cortical neurogenesis in vertebrates. J. Anat., 211 (2007) 
164- 176 
References 	  
54	  	  
• CHING, Y. P.; QI, Z.; WANG, J. H. - Cloning of three novel neuronal Cdk5 
activator binding proteins. Gene, 242(1–2) (2000) 285–294 
• CLARKE, J. - Live imaging of development in fish embryos. MRC Seminars in Cell 
& Developmental Biology 20 (2009) 942–9460 
• DONG, Z.; YANG, N.; YEO, S. Y.; CHITNIS, A.; GUO, S. - Intralineage 
directional Notch signaling regulates self-renewal and differentiation of 
asymmetrically dividing radial glia. Neuron. 74 (2012) 65-78 
• EVANS, P. D.; VALLENDER, E. J.; LAHN, B. T. - Molecular evolution of the brain 
size regulator genes CDK5RAP2 and CENPJ. Gene,375 (2006) 75–79 
• FARAG, H. G.; FROEHLER, S.; OEXLE, K.; RAVINDRAN, E.; SCHINDLER, D.; 
STAAB, T.; HUEBNER, A.; KRAEMER, N.; CHEN, W.; and KAINDL, A. M. - 
Abnormal centrosome and spindle morphology in a patient with autosomal 
recessive primary microcephaly type 2 due to compound heterozygous WDR62 
gene mutation. Orphanet Journal of Rare Diseases 8:178 (2013) 
• FISH, J. L.; KOSODO, Y.; ENARD, W.; PAABO, S. and HUTTNER, W. B. - Aspm 
specifically maintains symmetric proliferative divisions of neuroepithelial cells 
Jennifer. PNAS, 103 (2006) 10438-10443 
• FONG, K. W.; CHOI, Y. K.; RATTNER, J. B. and QI, R. Z. - CDK5RAP2 is a 
pericentriolar protein that functions in centrosomal attachment of the {gamma}- 
tubulin ring complex. Mol. Biol. Cell. 19 (2008) 115-125 
• FONG, K. W.; HAU, S. Y.; KHO, Y. S.; JIA, Y.; HE, L.; QI, R. Z. - Interaction of 
CDK5RAP2 with EB1 to track growing microtubule tips and to regulate 
microtubule dynamics. Mol. Biol. Cell. (2009) 
• FUJIMORI, A.; ITOH, K.; GOTO, S.; HIRAKAWA, H.; WANGA, B.; KOKUBOA, 
T.; KITO, S.; TSUKAMOTO, S.; FUSHIKI, S. - Disruption of Aspm causes 
microcephaly with abnormal neuronal differentiation. Brain Dev (2013) 
• HAREN, L.; REMY, M. H.; BAZIN, I.; CALLEBAUT, I.;WRIGHT, M.; and MERDES, 
A. - NEDD1-dependent recruitment of the gamma-tubulin ring complex to the 
cen- trosome is necessary for centriole duplication and spindle assembly. J. Cell 
Biol. 172 (2006) 505–515 
• HALBRITTER, J. 1.; BIZET, A. A.; SCHMIDTS, M.; PORATH, J. D.; BRAUN, D. A.; 
GEE, H. Y.; MCLNERNEY-LEO, A. M.; KRUG, P.; FILHOL, E.; DAVIS, E. E.; AIRIK, 
R.; CZARNECKI, P. G.; LEHNAM, A. M.; TRNKA, P.; NITSCHKÉ, P.; BOLE-
References 	  
55	  	  
FEYSOT, C.; SCHUELER, M.; KNEBELMANN, B.; BURTEY, S.; SZABÓ, A. J.; 
TORY, K.; LEO, P. J.; GARDINER, B.; MCKENZIE, F. A.; ZANKL, A.; BROWN, 
M. A.; HARTLEY, J. L.; MAHER, E. R.; LI, C.; LEROUX, M. R.; SCAMBLER, P. J.; 
ZHAN, S. H.; JONES, S. J.; KAYSERILI, H.; TUYSUZ, B.; MOORANI, K. N.; 
CONSTANTINESCU, A.; KRANZ, I. D.; KAPLAN, B. S.; SHAH, J. V.; UK10K 
Consortium; HURD, T. W.; DOHERTY, D.; KATSANIS, N.; DUNCAN, E. L.; 
OTTO, E. A.; BEALES, P. L.; MITCHISON, H. M.; SAUNIER, S.; HILDEBRANDT, 
F. - Defects in the IFT-B component IFT172 cause Jeune and Mainzer-Saldino 
syndromes in humans. Am J Hum Genet. 93 (2013) 915-25 
• HASSAN, M. J.; KHURSHID, M.; AZEEM, Z.; JOHN, P.; ALI, G.; CHISHTI, M. S.; 
AHMAD, W. - Previously described sequence variant in CDK5RAP2 gene in a 
Pakistani family with autosomal recessive primary microcephaly. BMC Med Genet 
8:58 (2007) 
• HIRANO, T. - SMC proteins and chromosome mechanics: from bacteria to 
humans. Philos Trans R Soc Lond B Biol Sci, 360(1455) (2005) 507–514 
• HONG, Y. R.; CHEN, C. H.; CHUO, M. H.; LIOU, S. Y.; HOWNG, S. L. - 
Genomic organization and molecular characterization of the human ninein gene. 
Biochem Biophys Res Commun. 279 (2000) 989-95. 
• HUTTNER, W. B. and KOSODO, Y. - Symmetric versus asymmetric cell division 
during neurogenesis in the developing vertebrate central nervous system. Current 
Opinion in Cell Biology 17 (2005) 648–657 
• ISSA, L.; MUELLER, K.; SEUFERT, K.; KRAEMER, N.; ROSENKOTTER, H.; 
NINNEMANN, O.; BUOB, M.; KAINDL, A. M. and MORRIS-ROSENDAHL, D. J. 
(2013 a) - Clinical and cellular features in patients with primary autosomal 
recessive microcephaly and a novel CDK5RAP2 mutation.  Orphanet Journal of 
Rare Diseases (2013) 8:59 
• ISSA, L.; KRAEMER, N.; RICKERT, C. H.; SIFRINGER, M.; NINNEMANN, O.; 
STOLTENBURG-DIDINGER, G. and KAINDL, A. M. (2013 b) CDK5RAP2 
Expression During Murine and Human Brain Development Correlates with 
Pathology in Primary Autosomal Recessive Microcephaly. Cerebral Cortex 
September, 23 (2013) 2245–2260  
References 	  
56	  	  
• JIA, Y.; FONG, K-W.; CHOI, Y-K.; SEE, S-S.; QI, R. Z. - Dynamic Recruitment of 
CDK5RAP2 to Centrosomes Requires Its Association with Dynein. PLoS ONE 8 
(2013)  
• JIANG, H.; LUO, S.; LI, H. - Cdk5 activator-binding protein C53 regulates 
apoptosis induced by genotoxic stress via modulating the G2/M DNA damage 
checkpoint. J. Biol. Chem., 280(21) (2005) 20651–20659  
• JIANG, H.; WU, J.; HE, C.; YANG, W.; LI, H. - Tumor suppressor protein C53 
antagonizes checkpoint kinases to promote cyclin-dependent kinase 1 activation. 
Cell. Res., 19(4) (2009)458–468 
• KAINDL, A. M.; PASSEMARD, S.; KUMAR, P.; KRAEMER, N.; ISSA, L.; ZWINER, 
A.; GERARD, B.; VERLOES, A.; MANI, S.; GRESSENS, P. - Many roads lead to 
primary autosomal recessive microcephaly. Prog Neurobiol. 90 (2010) 363-83 
• KIMMEL, C. B.; BALLARD, W. W.; KIMMEL, S. R.; ULLMANN, B. and 
SCHILLING, T. F. - Stages of embryonic development of the zebrafish. 
Developmental Dynamics 203 (1995)253-310 
• KONNO, D.; SHIOI, G.; SHITAMUKAI, A.; MORI, A.; KIYONARI, H.; MIYATA, 
T. and MATSUZAKI, F. Neuroepithelial progenitors undergo LGN-dependent 
planar divisions to maintain self-renewability during mammalian neurogenesis. Nat. 
Cell Biol. 10 (2008) 93–101 
• KRAEMER, N.; ISSA, L.; HAUCK, S. C. R.; MANI, S.; NINNEMANN, O.; KAINDL, 
A. M. - What´s the hype abaout CDK5RAP2?. Cell. Mol. Life Sci., 68 (2011) 1719-
1736 
• KRIEGSTEIN, A., NOCTOR, S. and MARTINEZ-CERDENO, V. - Patterns of 
neural stem and progenitor cell division may underlie evolutionary cortical 
expansion. Nat. Rev. Neurosci. 7 (2006) 883-890 
• LANCASTER, M. A.; RENNER, M.; MARTIN, C. A.; WENZEL, D.; BICKNELL, L. 
S.; HURLES, M. E.; HOMFRAY, T.; PENNINGER, J. M.; JACKSON, A. P.; 
KNOBLICH, J. A. - Cerebral organoids model human brain development and 
microcephaly. Nature. 501 (2013) 373-9 
• LEUNG, L.; KLOPPER, A. V.; GRILL, S. W.; HARRIS, W. A. and NORDEN, C. – 
Apical migration of nuclei during G2 is a prerequisite for all nuclear motion in 
zebrafish neuroepithelia. Development 138 (2011) 5003-5013 
References 	  
57	  	  
• LIZARRAGA, S. B.; MARGOSSIAN, S. P.; HARRIS, M. H.; CAMPGNA, D. R.; 
HAN, A-P; BLEVINS, S.; MUDBHARY, R.; BARKER, J. E.; WALSH, C. A. and 
FLEMING, M. D. - Cdk5rap2 regulates centrosome function and chromosome 
segregation in neuronal progenitors. Development, 137 (2010) 1907-1917 
• MEGRAW, T. L.; SHARKEY, J. T. and NOWAKOSKI, R. S. - Cdk5rap2 exposes 
the centrosomal root of microcephaly syndromes. Trends in Cell Biology., 21(8) 
(2011) 470-480 
• MITCHISON, H. M.; SCHMIDTS, M.; LOGES, N. T.; FRESHOUR, J.; DRITSOULA, 
A.; HIRST, R. A.; O'CALLAGHAN, C.; BLAU, H.; AL DABBAGH, M.; OLBRICH, 
H.; BEALES, P. L.; YAGI, T.; MUSSAFFI, H.; CHUNG, E. M.; OMRAN, H.; 
MITCHELL, D. R. - Mutations in axonemal dynein assembly factor DNAAF3 cause 
primary ciliary dyskinesia. Nat Genet. 44 (2012) 381-9, S1-2 
• MOCHIDA, G. H. - Molecular genetics of lissencephaly and microcephaly. Brain 
Nerve, 60 (2008) 437-444 
• MORIN, X. and BALLAICHE, Y. - Mitotic Spindle Orientation in Asymmetric and 
Symmetric Cell Divisions during Animal Development. Developmental Cell 21 
(2011) 102-119 
• NAGASE, T.; KIKUNO, R.; NAKAYAMA, M.; HIROSAWA, M.; OHARA, O. - 
Prediction of the coding sequences of unidentified human genes. XVIII. The 
complete sequences of 100 new cDNA clones from brain which code for large 
proteins in vitro. DNA Res., 7(4) (2000) 273–281 
• NIEUWENHUYS, R. - The neocortex. An overview of its evolutionary 
development, structural organization and synaptology. Anat. Embryol. (Berl.), 190 
(1994) 307-337 
• NOCTOR, S. C.; MARTÍNEZ-CERDEÑO, V.; KRIEGSTEIN, A. R. - Distinct 
behaviors of neural stem and progenitor cells underlie cortical neurogenesis. J 
Comp Neurol. 508 (2008) 28-44 
• PAGNAMENTA, A. T.; MURRAY, J. E.; YOON, G.; AKHA, E. S.; HARRISON, V.; 
BICKNELL, L. S.; AJILOGBA, K.; STEWART, H.; KINI, U.; TAYLOR, J. C.; KEAYS, 
D. A.; JACKSON, A. P.; KNIGHT, S. J. L. - A novel nonsense CDK5RAP2 
mutation in a Somali child with primary microcephaly and sensorineural hearing 
loss. Am J Med Genet Part A 158A (2012) 2577–2582 
References 	  
58	  	  
• PARK, H-C. and APPEL, B. -  Delta-Notch signaling regulates oligodendrocyte 
specification 3747. Development 130 (2003) 3747-3755 
• RAUF and MIR: Exploring evolution of brain genes involved in microcephaly 
through phylogeny and synteny analysis. Theoretical Biology and Medical 
Modelling, 10 (2013) 61 
• REVENKOVA, E.; EIJPE, M.; HEYTING, C.; GROSS, B.; JESSBERGER, R. - Novel 
meiosis-specific isoform of mammalian SMC1. Mol. Cell. Biol., 21(20) (2001) 6984–
6998 
• RIMOL, L. M.; AGARTZ, I.; DJUROVIC, S.; BROWN, A. A.; RODDEY, J. C.; 
KÄHLER, A. K.; MATTINGSDAL, M.; ATHANASIU, L.; JOYNER, A. H.; 
SCHORK, N. J.; HALGREN, E.; SUNDET, K.; MELLE, I.; DALE, A. M.; 
ANDREASSEN, O. A.; Alzheimer's Disease Neuroimaging Initiative. - Sex-
dependent association of common variants of microcephaly genes with brain 
structure. Proc Natl Acad Sci U S A.107 (2010) 384-8 
• SETSUKO, S. and LEARY, D. D. M. O. - Fgf10 Regulates Transition Period of 
Cortical Stem Cell Differentiation to Radial Glia Controlling Generation of 
Neurons and Basal Progenitors. Neuron   63 (2009) 48-62  
• SHI, L.; LIN, Q.; SU, B. - Human-specific hypomethylation of CENPJ, a key brain 
size regulator. Mol Biol Evol. 31 (2014) 594-604. 
• TAN, C. A.; TOPPER, S.; MELVER, C. W.; STEIN, J.; REEDER, A.; ARNDT, K.; 
DAS, S. - The first case of CDK5RAP2-related primary microcephaly in a non-
consaguineous patient identified by next deneration sequencing. Brain Dev, (2013) 
(case report) 
• TANG, C. J.; FU, R. H.; WU, K. S.; HSU, W. B.; TANG, T. K. - CPAP is a cell-
cycle regulated protein that controls centriole length. Nat Cell Biol. 11 (2009) 
825-31 
• TAWK, M.; ARAYA, C.; LYONS, D. A.; REUGELS, A. M.; GIRDLER, G. C.; 
BAYLEY P. R. - A mirrordsymmetric cell division that orchestrates neuroepithelial 
morphogenesis. Nature 446 (2007) 797-800 
• WANG, X.; TSAI, J. W.; IMAI, J. H.; LIAN, W. N.; VALLEE, R. B. and SHI, S. H. - 
Asymmetric centrosome inheritance maintains neural progenitors in the 
neocortex. Nature, 461 (2009) 947-955 
References 	  
59	  	  
• WANG, Z.; WU, T.; SHI, L.; ZHANG, L.; ZHENG, W.; QU, J. Y.; NIU, R.; QI, R. 
Z. - A conserved motif of CDK5RAP2 mediates its localization to centrosomes 
and the Golgi complex. J. Biol. Chem. (2010) 
• WESTERFIELD, M. - The Zebrafish Book. Eugene: University of Oregon, 2009 
• WOODS, C. G.; BOND, J. and ENARD, W. - Autosomal recessive primary 
microcephaly (MCPH): a review of clinical, molecular, and evolutionary findings. 
Am. J. Hum. Genet., 76 (2005) 717-728 
• WOODS, C. G. and PARKER, A. - Investigating microcephaly. Arch Dis Child, 98 
(2013) 707–713 
• ZHONG, W. and CHIA, W. - Neurogenesis and asymmetric cell division. Curr. 
Opin. Neurobiol., 18 (2008) 4-11 
 
